Inmune Bio Inc. (INMB) at a glance

Inmune Bio Inc. (INMB) is a micro-cap Healthcare company. It trades at $1.43, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 35/100 overall. Its strongest dimension is Value (53/100) and its weakest is Growth (10/100). Its volatility is roughly in line with the market.

Price
$1.43
Market cap
$33.0M
P/E ratio
n/a
Dividend yield
None
Beta
1.01
52-week range
$1.09 to $11.64
Vestovix Score35/ 100How this works
Value
53
Growth
10
Income
40
Safety
50
Momentum
14

Other Healthcare stocks

See all